Publication Name	World Journal of Clinical Cases
Manuscript ID	56992
Country	China

Received	2020-05-28 14:43
Peer-Review Started	2020-05-28 14:43
To Make the First Decision
Return for Revision	2020-09-13 14:44
Revised	2020-09-26 15:55
Second Decision	2020-10-16 11:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-10-20 04:00
Articles in Press	2020-10-20 04:00
Publication Fee Transferred
Edit the Manuscript by Language Editor	2020-11-02 00:44
Typeset the Manuscript	2020-11-30 01:47
Publish the Manuscript Online	2020-12-04 09:56

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Report
Article Title	Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Wei-Hong Yu, Xie-Jia Li and Fang Yuan
ORCID	Author(s) ORCID Number Wei-Hong Yu http://orcid.org/0000-0002-4449-7536 Xie-Jia Li http://orcid.org/0000-0002-8163-814X Fang Yuan http://orcid.org/0000-0002-5034-6603
Funding Agency and Grant Number	Funding Agency Grant Number the National Natural Science Foundation of China 81770730 the Hunan Provincial Natural Science Fund 2017JJ2352
Corresponding Author	Fang Yuan, MD, PhD, Chief Doctor, Department of Nephrology, the Second Xiangya Hospital of Central South University, No. 139 Renmin Road, Changsha 410011, Hunan Province, China. yuanfang@csu.edu.cn
Key Words	Renal anemia; Erythropoietin hyporesponsiveness; Hepcidin; Interleukin 6; Roxadustat; Case report
Core Tip	We present a case of refractory erythropoiesis-stimulating agents hyporesponsiveness-related anemia in which oral roxadustat increased and maintained hemoglobin. Roxadustat may be a useful optional treatment for anemia in chronic kidney disease. Future clinical trials are needed to assess potential problems with hypoxia-inducible factor prolyl hydroxylase inhibitors.
Publish Date	2020-12-04 09:56
Citation	Yu WH, Li XJ, Yuan F. Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report. World J Clin Cases 2020; 8(23): 6048-6055
URL	https://www.wjgnet.com/2307-8960/full/v8/i23/6048.htm
DOI	https://dx.doi.org/10.12998/wjcc.v8.i23.6048

Full Article (PDF)	WJCC-8-6048.pdf
Full Article (Word)	WJCC-8-6048.docx
CARE Checklist–2016	56992-CARE-Checklist–2016-revision.pdf
Manuscript File	56992_Auto_Edited_WangTQ.docx
Answering Reviewers	56992-Answering reviewers.pdf
Audio Core Tip	56992-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	56992-Conflict-of-interest statement.pdf
Copyright License Agreement	56992-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	56992-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	56992-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	56992-Language certificate.pdf
Peer-review Report	56992-Peer-review(s).pdf
Scientific Misconduct Check	56992-Bing-Wang JL-1.jpg
Scientific Misconduct Check	56992-Scientific misconduct check.pdf
Scientific Editor Work List	56992-Scientific editor work list.pdf